Glenmark Nashik Employees volunteer time and service for less privileged children at Sawargaon Village

Author(s): City Air NewsEmployees based at Glenmark’s manufacturing facility at Nashik, volunteer their services for the benefit of the less privileged children of Sawargaon village. Nashik, April 2, 2014: Over 100 employees based at Glenmark’s...

Glenmark Nashik Employees volunteer time and service for less privileged children at Sawargaon Village
Author(s): 

Employees based at Glenmark’s manufacturing facility at Nashik, volunteer their services for the benefit of the less privileged children of Sawargaon village.

Nashik, April 2, 2014: Over 100 employees based at Glenmark’s manufacturing facility at Nashik, volunteered their services for the benefit of the less privileged children of Sawargaon village. The initiative was conducted in association with Yuva Parivartan, a NGO working towards providing livelihoods to underprivileged youth.

Glenmark employees organized a health camp for the school children and educated them about healthy habits and hygiene. They dedicated an entire day in Shramdaan (voluntary physical labour) for cleaning and beautifying the village especially the village school. Employees undertook a rally along with the school children to spread awareness about ‘Saving the Girl Child.’

Said Jalaj Sharma, Director & President Operations – Glenmark; “We at Glenmark believe in the philosophy of ‘Enriching Lives’ and we strive to make a positive difference in lives of the communities where we operate. I am delighted that over 100 employees of our Nashik plant volunteered their services and valuable time for the benefit of the school children in Sawargaon. We would like to urge more and more people to start volunteering time with social organizations as this is very important for the overall development of society”.

Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company headquartered at Mumbai, India. It is ranked among the top 80 Pharma & Biotech companies of the world in terms of revenues. (SCRIP 100 Rankings published in the year 2013).

Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is primarily focused in the areas of Inflammation [asthma/COPD, rheumatoid arthritis etc.] and Pain [neuropathic pain and inflammatory pain].

Date: 
Wednesday, April 2, 2014